KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Total Liabilities (2016 - 2025)

Resmed (RMD) has disclosed Total Liabilities for 16 consecutive years, with $2.2 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities rose 15.58% year-over-year to $2.2 billion, compared with a TTM value of $2.2 billion through Dec 2025, up 15.58%, and an annual FY2025 reading of $2.2 billion, up 9.87% over the prior year.
  • Total Liabilities was $2.2 billion for Q4 2025 at Resmed, roughly flat from $2.2 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $2.9 billion in Q4 2022 and bottomed at $1.6 billion in Q4 2021.
  • Average Total Liabilities over 5 years is $2.1 billion, with a median of $2.0 billion recorded in 2024.
  • The sharpest move saw Total Liabilities soared 84.91% in 2022, then fell 23.4% in 2024.
  • Year by year, Total Liabilities stood at $1.6 billion in 2021, then skyrocketed by 84.91% to $2.9 billion in 2022, then dropped by 17.52% to $2.4 billion in 2023, then dropped by 22.07% to $1.9 billion in 2024, then increased by 15.58% to $2.2 billion in 2025.
  • Business Quant data shows Total Liabilities for RMD at $2.2 billion in Q4 2025, $2.2 billion in Q3 2025, and $2.2 billion in Q2 2025.